Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,298.00
(
0.69%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
99.95
(
-0.70%
)
Bitcoin
74,020.94
(
0.11%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

exwannabe

Send PM Follow Ignore
Followers 91
Posts 20561
Boards Moderated 0
Alias Born 09/06/2006

exwannabe

Re: jbog post# 114354

Tuesday, 02/08/2011 11:21:14 PM

Tuesday, February 08, 2011 11:21:14 PM

Post# of 257253


While it is somewhat farfetched, I wouldn't put it past Teva if they looked to buy Momenta and fund the whole transaction by selling Momenta's portion of the copaxone franchise to Sandoz.



That would also not fly by the FTC/DoJ very well. You are still putting the only 2 potential Copox products in the same hands.

EDIT: Miss-read your post, I agree that would work but why would TEVA care to do so?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now